Urologic Oncology Program

The Urologic Oncology Program at the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute offers patients access to emerging therapies through its research programs. Those programs include integrated clinical trials and a translational research lab that supports pre-clinical and clinical drug studies for cancers associated with:

• Prostate cancer
• Bladder cancer
• Kidney cancer
• Adrenal cancer
• Testicular cancer
• Penile cancer

In an ongoing effort to build one of the nation's leading research facilities, the program is staffed by high level research professionals. This team is on a campaign to find a cure for prostate cancer and collaborates with other leading specialists through the country. The program's team exchanges research and clinical insights to advance the fight against prostate cancer and, thanks to video conferencing, our physicians are able to communicate in real time with academic, scientific and clinical colleagues anywhere in the world, working as a virtual team.

The Urologic Oncology Program brings together a robust team of clinicians and researchers working together to bring lifesaving medicine and transformative care to patients.